{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:38:37Z","timestamp":1790127517221,"version":"4.0.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009572","name":"Universit\u00e4t St. Gallen","doi-asserted-by":"publisher","award":["Seed Money Grants Call of 2019"],"award-info":[{"award-number":["Seed Money Grants Call of 2019"]}],"id":[{"id":"10.13039\/100009572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic Chagas Cardiomyopathy (CCM) is characterized by a unique pathophysiology in which inflammatory, microvascular and neuroendocrine processes coalesce in the development of one of the most severe cardiomyopathies affecting humans. Despite significant advances in understanding the molecular mechanisms involved in this disease, scarce information is available regarding microRNAs and clinical parameters of disease severity. We aimed to evaluate the association between circulating levels of six microRNAs with markers of myocardial injury and prognosis in this population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with CCM and reduced ejection fraction were included in a prospective exploratory cohort study. We assessed the association of natural log-transformed values of six circulating microRNAs (miR-34a-5p, miR-208a-5p, miR-185-5p, miR-223-5p, let-7d-5p, and miR-454-5p) with NT-proBNP levels and echocardiographic variables using linear regression models adjusted for potential confounders. By using Cox Proportional Hazard models, we examined whether levels of microRNAs could predict a composite outcome (CO), including all-cause mortality, cardiac transplantation, and implantation of a left ventricular assist device (LVAD). Finally, for mRNAs showing significant associations, we predicted the target genes and performed pathway analyses using Targetscan and Reactome Pathway Browser.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventy-four patients were included (59% males, median age: 64 years). After adjustment for age, sex, body mass index, and heart failure medications, only increasing miR-223-5p relative expression levels were significantly associated with better myocardial function markers, including left atrium area (Coef. -10.2; 95% CI -16.35; -4.09), end-systolic (Coef. -45.3; 95% CI -74.06; -16.61) and end-diastolic volumes (Coef. -46.1; 95% CI -81.99; -10.26) of the left ventricle. Moreover, we observed that higher miR-223-5p levels were associated with better left-ventricle ejection fraction and lower NT-proBNP levels. No associations were observed between the six microRNAs and the composite outcome. A total of 123 target genes for miR-223-5p were obtained. From these, several target pathways mainly related to signaling by receptor tyrosine kinases were identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The present study found an association between miR-223-5p and clinical parameters of CCM, with signaling pathways related to receptor tyrosine kinases as a potential mechanism linking low levels of miR-223-5p with CCM worsening.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2022.922189","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T06:10:35Z","timestamp":1659939035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy"],"prefix":"10.3389","volume":"12","author":[{"given":"Sergio Alejandro","family":"G\u00f3mez-Ochoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Katherine","family":"Bautista-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyda Z.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hunziker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taulant","family":"Muka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Echeverr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejim.2017.05.001","article-title":"Chagas disease in Europe: A review for the internist in the globalized world","volume":"43","author":"Antinori","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1086\/345882","article-title":"Implication of transforming growth factor-beta1 in chagas disease myocardiopathy","volume":"186","author":"Ara\u00fajo-Jorge","year":"2002","journal-title":"J. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40659-021-00345-3","article-title":"Circulating miR-146a as a possible candidate biomarker in the indeterminate phase of chagas disease","volume":"54","author":"Ballinas-Verdugo","year":"2021","journal-title":"Biol. Res."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090337","article-title":"Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy","volume":"9","author":"Bernardo","year":"2014","journal-title":"PloS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e00023","DOI":"10.1128\/CMR.00023-19","article-title":"Chagas disease in the united states: a public health approach","volume":"33","author":"Bern","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.15420\/cfr.2016:14:2","article-title":"Chagas heart failure in patients from Latin America","volume":"2","author":"Bestetti","year":"2016","journal-title":"Card. Fail Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ajpath.2014.12.023","article-title":"Autoimmune pathogenesis of chagas heart disease: looking back, looking ahead","volume":"185","author":"Bonney","year":"2015","journal-title":"Am. J. Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-pathol-020117-043711","article-title":"Pathology and pathogenesis of chagas heart disease","volume":"14","author":"Bonney","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.actatropica.2016.01.002","article-title":"A global systematic review of chagas disease prevalence among migrants","volume":"156","author":"Conners","year":"2016","journal-title":"Acta Trop."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E545","DOI":"10.3390\/ijms20030545","article-title":"5p and 3p strands of miR-34 family members have differential effects in cell proliferation, migration, and invasion in cervical cancer cells","volume":"20","author":"C\u00f3rdova-Rivas","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3632906","DOI":"10.1155\/2019\/3632906","article-title":"Cardiac chagas disease: MMPs, TIMPs, galectins, and TGF-\u03b2 as tissue remodelling players","volume":"2019","author":"da Costa","year":"2019","journal-title":"Dis. Markers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.idc.2018.10.015","article-title":"American Trypanosomiasis (Chagas disease)","volume":"33","author":"Echeverria","year":"2019","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.thromres.2021.02.025","article-title":"Coagulation disorders in chagas disease: A pathophysiological systematic review and meta-analysis","volume":"201","author":"Echeverr\u00eda","year":"2021","journal-title":"Thromb. Res."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007602","article-title":"TGF-\u03b2 inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic chagas\u2019 heart disease","volume":"13","author":"Ferreira","year":"2019","journal-title":"PloS Negl. Trop. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.imbio.2016.01.009","article-title":"Proteins involved on TGF-\u03b2 pathway are up-regulated during the acute phase of experimental chagas disease","volume":"221","author":"Ferreira","year":"2016","journal-title":"Immunobiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17990","DOI":"10.1038\/s41598-017-18080-9","article-title":"Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute trypanosoma cruzi infection","volume":"7","author":"Ferreira","year":"2017","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ijcard.2014.05.019","article-title":"MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in chronic chagas disease cardiomyopathy","volume":"175","author":"Ferreira","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1161\/CIRCULATIONAHA.116.026240","article-title":"Cardioprotective role of tumor necrosis factor receptor-associated factor 2 by suppressing apoptosis and necroptosis","volume":"136","author":"Guo","year":"2017","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3201\/eid2702.191795","article-title":"Plasma MicroRNA profiling of plasmodium falciparum biomass and association with severity of malaria disease","volume":"27","author":"Gupta","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.396","article-title":"Plasma levels of hsa-miR-3158-3p microRNA on admission correlate with MRI findings and predict outcome in cerebral malaria","volume":"11","author":"Gupta","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.773314","article-title":"miR-208a in cardiac hypertrophy and remodeling","volume":"8","author":"Huang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e00948","DOI":"10.1128\/IAI.00948-19","article-title":"MicroRNA-155 deficiency exacerbates trypanosoma cruzi infection","volume":"88","author":"Jha","year":"2020","journal-title":"Infect. Immun."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008889","article-title":"miRNAs may play a major role in the control of gene expression in key pathobiological processes in chagas disease cardiomyopathy","volume":"14","author":"Laugier","year":"2020","journal-title":"PloS Negl. Trop. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.114.011195","article-title":"Transforming growth factor \u03b2-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling","volume":"130","author":"Li","year":"2014","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00269","article-title":"Circulating plasma MicroRNA-208a as potential biomarker of chronic indeterminate phase of chagas disease","volume":"9","author":"Linhares-Lacerda","year":"2018","journal-title":"Front. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00428","article-title":"Differential expression of microRNAs in thymic epithelial cells from trypanosoma cruzi acutely infected mice: Putative role in thymic atrophy","volume":"6","author":"Linhares-Lacerda","year":"2015","journal-title":"Front. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.3390\/ijms15045774","article-title":"Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction","volume":"15","author":"Lv","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0002-9440(10)63019-2","article-title":"Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during trypanosoma cruzi infection","volume":"159","author":"Michailowsky","year":"2001","journal-title":"Am. J. Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1261\/rna.048132.114","article-title":"Concordant dysregulation of miR-5p and miR-3p arms of the same precursor microRNA may be a mechanism in inducing cell proliferation and tumorigenesis: a lung cancer study","volume":"21","author":"Mitra","year":"2015","journal-title":"RNA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","article-title":"Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure","volume":"124","author":"Montgomery","year":"2011","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003828","article-title":"MicroRNA transcriptome profiling in heart of trypanosoma cruzi-infected mice: Parasitological and cardiological outcomes","volume":"9","author":"Navarro","year":"2015","journal-title":"PloS Negl. Trop. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"E4064","DOI":"10.3390\/ijms20164064","article-title":"Circulating miRNAs as potential biomarkers associated with cardiac remodeling and fibrosis in chagas disease cardiomyopathy","volume":"20","author":"Nonaka","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1161\/CIR.0000000000000599","article-title":"Chagas cardiomyopathy: An update of current clinical knowledge and management: A scientific statement from the American heart association","volume":"138","author":"Nunes","year":"2018","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00161","article-title":"The role of microRNAs in heart failure: A systematic review","volume":"7","author":"Peterlin","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"20247","DOI":"10.1074\/jbc.M116.732735","article-title":"MicroRNA-223-5p and -3p cooperatively suppress necroptosis in Ischemic\/Reperfused hearts","volume":"291","author":"Qin","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card. Fail Rev."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004361","article-title":"Contemporary characteristics and outcomes in chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy","volume":"10","author":"Shen","year":"2017","journal-title":"Circ. Heart Fail"},{"key":"B39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni.3206","article-title":"The diverse role of RIP kinases in necroptosis and inflammation","volume":"16","author":"Silke","year":"2015","journal-title":"Nat. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.bbadis.2014.03.005","article-title":"miR-223: An inflammatory oncomiR enters the cardiovascular field","volume":"1842","author":"Ta\u00efbi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000393","article-title":"Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load","volume":"2","author":"Tzelepis","year":"2007","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.bbadis.2016.11.034","article-title":"The role of microRNAs in heart failure","volume":"1863","author":"Wang","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.bbadis.2014.01.012","article-title":"Loss of MiR-223 duplex (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jfma.2013.01.002","article-title":"Mechanical stretch via transforming growth factor-\u03b21 activates microRNA-208a to regulate hypertrophy in cultured rat cardiac myocytes","volume":"112","author":"Wang","year":"2013","journal-title":"J. Formos. Med. Assoc."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084188","article-title":"MicroRNA-208a increases myocardial fibrosis via endoglin in volume overloading heart","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCRESAHA.117.305962","article-title":"MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction","volume":"117","author":"Yang","year":"2015","journal-title":"Circ. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.bbadis.2016.08.009","article-title":"MicroRNAs in heart failure: Non-coding regulators of metabolic function","volume":"1862","author":"Zhang","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.922189\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T06:10:38Z","timestamp":1659939038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.922189\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":47,"alternative-id":["10.3389\/fcimb.2022.922189"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.922189","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]},"article-number":"922189"}}